| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |